Boswellia
Boswellia resin extracts marketed mainly for inflammatory or joint conditions. Reviews describe promising but product-specific clinical signals alongside major formulation, bioavailability, and evidence-quality limitations.
Pharmacokinetic model
A route-level PK model for boswellia is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Herb
- Suggested cadence
- once daily
Research behind this entry
-
Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data
Review integrated extract chemistry, constituent pharmacokinetics, preclinical mechanisms, and early clinical studies. It emphasized poor and variable oral bioavailability of several boswellic acids and the need to…
-
Boswellia: an evidence-based systematic review by the Natural Standard Research Collaboration
Evidence review surveyed clinical indications, dosing, safety, and product issues. The limited and heterogeneous trials available at the time did not establish broad efficacy for generic Boswellia products.
-
A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
This citation reports a human clinical study involving Boswellia. It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
3 published studies referenced in the app, each with a plain-language summary.